Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hemoboost
- Development stage
- Phase 1
- Lead developer
- Paawan Herbal
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Intravenous, Intramuscular, Oral
01
Overview
Hemoboost is a registered natural product formulated for iron substitution. It contains specially processed haemolysed haemoglobin and iron dextran. Initially used in veterinary medicine, it is now marketed for human use, particularly for addressing symptom-producing anaemia, such as that which can occur after total knee arthroplasty. The product aims to provide iron supplementation with a focus on reducing the gastrointestinal adverse effects commonly associated with traditional iron supplements like ferrous sulphate.
- Brand names
- Hemoboost
02
Targets
FTH1 (Ferritin heavy chain 1)
Beyond the preview
Go deeper on Hemoboost.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemoboost.